|
99
|
297
|
3m2wA |
Crystal structure of mapkak kinase 2 (mk2) complexed with a spiroazetidine-tetracyclic atp site inhibitor |
|
41
|
201
|
3m9gA |
Crystal structure of the three-pasta-domain of a ser/thr kinase from staphylococcus aureus |
|
111
|
330
|
3mb7A |
Human ck2 catalytic domain in complex with a difurane derivative inhibitor (amr) |
|
75
|
266
|
3m11A |
Crystal structure of aurora a kinase complexed with inhibitor |
|
98
|
302
|
3mftA |
Cask-4m cam kinase domain, mn2+ |
|
95
|
302
|
3mfuA |
Cask-4m cam kinase domain, amppnp-mn2+ |
|
86
|
269
|
3ma3A |
Crystal structure of human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and a naphtho-difuran ligand |
|
260
|
949
|
3l16A |
Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-pi3-kinase and dual pan-pi3-kinase/mtor inhibitors for the treatment of cancer |
|
107
|
427
|
3lj1A |
Ire1 complexed with cdk1/2 inhibitor iii |
|
261
|
949
|
3l17A |
Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-pi3-kinase and dual pan-pi3-kinase/mtor inhibitors for the treatment of cancer |
|
253
|
949
|
3l13A |
Crystal structures of pan-pi3-kinase and dual pan-pi3-kinase/mtor inhibitors |
|
112
|
427
|
3lj0A |
Ire1 complexed with adp and quercetin |
|
272
|
947
|
3l08A |
Structure of pi3k gamma with a potent inhibitor: gsk2126458 |
|
79
|
268
|
3lauA |
Crystal structure of aurora2 kinase in complex with a gsk3beta inhibitor |
|
35
|
197
|
3lpwA |
Crystal structure of the fniii-tandem a77-a78 from the a-band of titin |
|
271
|
952
|
3l54A |
Structure of pi3k gamma with inhibitor |
|
85
|
287
|
3lm0A |
Crystal structure of human serine/threonine kinase 17b (stk17b) |
|
89
|
284
|
3lm5A |
Crystal structure of human serine/threonine kinase 17b (stk17b) in complex with quercetin |
|
113
|
427
|
3lj2A |
Ire1 complexed with jak inhibitor i |
|
109
|
326
|
3kxmA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor k74 |
|
113
|
327
|
3kxnA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor tetraiodobenzimidazole (k88) |
|
49
|
196
|
3lcyA |
Titin ig tandem domains a164-a165 |
|
94
|
360
|
3l1sA |
3-aryl-4-(arylhydrazono)-1h-pyrazol-5-ones: highly ligand efficient and potent inhibitors of gsk3 |
|
108
|
327
|
3kxhA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl-acetic acid (k66) |
|
109
|
327
|
3kxgA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64) |
|
86
|
315
|
3kn5A |
Crystal structure of the c-terminal kinase domain of msk1 in complex with amp-pnp |
|
78
|
268
|
3kmwA |
Crystal structure of the ilk/alpha-parvin core complex (mgatp) |
|
92
|
318
|
3ka0A |
Mk2 complex with inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2-hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide |
|
20
|
76
|
3kucB |
Complex of rap1a(e30d/k31e)gdp with rafrbd(a85k/n71r) |
|
14
|
97
|
3khfA |
The crystal structure of the pdz domain of human microtubule associated serine/threonine kinase 3 (mast3) |
|
323
|
1165
|
3jbzA |
Crystal structure of mtor docked into em map of dimeric atm kinase |
|
66
|
267
|
3kmuA |
Crystal structure of the ilk/alpha-parvin core complex (apo) |
|
85
|
305
|
3kc3A |
Mk2 complexed to inhibitor n4-(7-(benzofuran-2-yl)-1h-indazol-5-yl)pyrimidine-2,4-diamine |
|
12
|
76
|
3kudB |
Complex of ras-gdp with rafrbd(a85k) |
|
50
|
124
|
3kh2A |
Crystal structure of the p1 bacteriophage doc toxin (f68s) in complex with the phd antitoxin (l17m/v39a). northeast structural genomics targets er385-er386 |
|
56
|
2410
|
3kgvA |
Crystal structure of human dna-dependent protein kinase catalytic subunit (dna-pkcs) |
|
21
|
98
|
3knbA |
Crystal structure of the titin c-terminus in complex with obscurin-like 1 |
|
90
|
297
|
3kgaA |
Crystal structure of mapkap kinase 2 (mk2) complexed with a potent 3-aminopyrazole atp site inhibitor |
|
93
|
315
|
3kn6A |
Crystal structure of the c-terminal kinase domain of msk1 |
|
135
|
506
|
3k0aA |
Crystal structure of the phosphorylation-site mutant s431a of the kaic circadian clock protein |
|
79
|
275
|
3jy0A |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
130
|
506
|
3k09A |
Crystal structure of the phosphorylation-site mutant s431d of the kaic circadian clock protein |
|
47
|
124
|
3k33A |
Crystal structure of the phd-doc complex |
|
131
|
506
|
3k0eA |
Crystal structure of the phosphorylation-site mutant t426n of the kaic circadian clock protein |
|
78
|
271
|
3jvsA |
Characterization of the chk1 allosteric inhibitor binding site |
|
129
|
488
|
3k0cC |
Crystal structure of the phosphorylation-site double mutant s431a/t432e of the kaic circadian clock protein |
|
147
|
491
|
3k0fB |
Crystal structure of the phosphorylation-site double mutant t426a/t432a of the kaic circadian clock protein |
|
80
|
274
|
3jxwA |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
145
|
506
|
3k0fA |
Crystal structure of the phosphorylation-site double mutant t426a/t432a of the kaic circadian clock protein |
|
152
|
484
|
3jzmA |
Crystal structure of the phosphorylation-site mutant t432a of the kaic circadian clock protein |
